Bicycle Therapeutics Shares Rise On Continuation Of BT8009 Development
Shares of Bicycle Therapeutics plc (BCYC) are up 9% on Monday after the company announced that it will proceed with its plan to expedite the development of BT8009 for metastatic bladder cancer.
Source: rttnews.com